 Showing 1351 to 1368 of 1475 messages
Date | Subject | Author | Discuss |
---|
06/6/2025 10:16:46 | Didnt opti announce 2 at 100 or 80p? isn't the reasoning there upon hindsight to see why? |  the gerbilator | |
06/6/2025 10:15:05 | It is interesting nevertheless |  netcurtains | |
06/6/2025 09:50:44 | RNS.. TWO brokers now.. Blimey. Is this a defensive move against a takeover... Or Is it an aggressive move to takeover another company... Or Is there a third reason |  netcurtains | |
06/6/2025 08:23:49 | 100 Years of Croda. Celebration/Anniversary |  netcurtains | |
05/6/2025 09:00:44 | the gerbiloon is awake |  min ping | |
05/6/2025 08:59:02 | Holders, note, 'the trend is your friend' - but only if a bear @CRDA PLC |  the gerbilator | |
02/6/2025 15:53:40 | It has quite a reasonable dividend too - between Tesco and Whitbread.... |  netcurtains | |
02/6/2025 12:27:31 | I always admired the crews in the UK
Imagine me x64000?
haha |  the gerbilator | |
02/6/2025 12:25:17 | ST: Croda at all the shows this week.... Should we expect a blip up in the price of Croda by the end of week? 😀 |  netcurtains | |
30/5/2025 08:46:00 | Still going up when we have been promised it will go to £10. How can this be….
#whataguru |  nobbygnome | |
28/5/2025 15:33:07 | Nobbygnome - 02 May 2025 - 15:14:15 - 834 of 970 CRODA - CRDA And half the remainder will go if it hits 20p bid later. You see I broadcast my trades in real time which Sheedy never does. Funny that
.........
Rumour has it he just did one for you and you missed it |  the gerbilator | |
28/5/2025 12:07:56 | Gone 12. SBTX going to need one hooky maker to try find gerbils there for much longer |  the gerbilator | |
28/5/2025 11:01:46 | How is it up yet again!?!
#whataguru |  nobbygnome | |
27/5/2025 22:53:32 | ffs does it ever end? back next week |  the gerbilator | |
27/5/2025 22:53:14 | RNS – 7:01 AM – Title: “Strategic Business Positioning Framework Initiative” SkinBioTherapeutics plc (AIM: SBTX) is pleased to announce that it has commenced an internal evaluation process designed to explore, align, and potentially realise synergistic opportunities across existing vertical innovation clusters within the core operational conceptual pipeline infrastructure.
CEO Stuart Ashman commented:
“We’re very excited to begin identifying the early-stage pre-commercial potential of platform-adjacent assets in the pre-scale discovery perimeter of our value matrix. It’s an important step in re-understanding what we might eventually consider doing, in a loose sense, should conditions evolve in an enabling direction.”
The market, confused and exhausted, shrugs. The share price drops another 33%.
...........
AGM 2025: The Reckoning A small rented room in London. Plastic chairs. Lukewarm coffee. Attendance: 28 confused retail holders, 2 analysts, 1 intern, and Veritas_CV88 — in a hoodie, holding a battered folder of printouts, spreadsheets, and every promise Ashman ever made.
Ashman takes the stage.
“Welcome. Let’s keep this civil. There’s a lot to get through — mostly my slides, which I made myself in PowerPoint 2007. A lot of blue gradients.”
But Veritas_CV88 stands. Quietly. Calmly.
“No slides, Stuart. Just questions.”
Ashman scoffs.
“And who exactly are you?”
“You know who I am.” |  the gerbilator | |
27/5/2025 21:42:58 | BREAKING: Patented Sock Hole “Communicates with Nervous System,”
Claims Startup — Trial Confirms Pain-Free Frostbite and Unexpected Enlightenment
New Zenahole™ Clinical Trial Leaves Scientists Speechless, Investors Reckless, and Tramps Reportedly Floating
In a finding that may redefine both footwear and neurology, scientists—or at least people in lab coats—have announced that the Zenahole™, a patented sock with a precision-engineered hole, “directly interfaces with the nervous system via dorsal plantar osmosis and biomechanical breathability feedback.”
What this means, according to the startup's Chief Quantum Sockologist Dr. Sierra O’Wool, is that:
“When the central void of the Zenahole aligns with the metatarsal epicenter, a sympathetic foot-field forms. This field bypasses traditional pain receptors and instead whispers calming affirmations into the peripheral nervous system, possibly in Morse code.”
The sock’s hole, measuring exactly π millimeters in diameter, is said to "harmonize somatic signals" by allowing thermal extremity to “vent back pain through the foot chakra.” In layman's terms: it’s cold, and you forget your spine exists.
To prove this revolutionary claim, the company conducted a clinical trial in rural Lapland involving 13 tramps, 2 thermal cameras, and one extremely confused ethics advisor. The tramps were exposed to -25°C conditions while wearing only the Zenahole socks and a hopeful smile.
Results were conclusive. All participants reported “no pain.” Experts suspect this may correlate with full neural shutdown, but Dr. O’Wool remains optimistic:
“Some were vibrating gently by day three. That’s not hypothermia—that’s resonance.”
One participant claimed his back pain disappeared entirely. Another said he saw a glowing archangel made of alpaca wool. A third just quietly asked if he could keep the socks, hole and all.
The socks are made from a proprietary blend of merino wool, carbon-neutral nano-yarn, and vague promise. The hole is laser-cut using what the company describes as "AI-enhanced guesswork."
The Zenahole will launch at £79.99 per pair, or £149.99 for the deluxe “Double Void” edition, which includes holes on both socks and a sticker that reads: “Reality Is Optional.”
Meanwhile, a major shareholder was contacted for comment outside a crypto-funded smoothie bar. He responded:
“Buy shares. Mine. As many as possible. These holes are the future—maybe even the past.”
The company has filed for seven new patents, including one for toe-specific neuro-portals and another for thermal minimalism apparel: essentially a scarf with a hole in it. |  the gerbilator | |
27/5/2025 21:32:43 | Zenahole™ |  the gerbilator | |
27/5/2025 21:29:03 | 'The patented hole in my sock cured my back and I can sleep again' |  the gerbilator | |
|
 Pepperstone74.8% of retail investor accounts lose money when trading spread bets and CFDs with this provider.  Plus50080% of retail CFD accounts lose money.  Pepperstone74.8% of retail investor accounts lose money when trading spread bets and CFDs with this provider.  MiTradeNot for UK customers - CFDs are complex instruments and entail a high risk of losing money rapidly due to leverage.  Plus50080% of retail CFD accounts lose money.  Pepperstone74.8% of retail investor accounts lose money when trading spread bets and CFDs with this provider.  Interactive BrokersInvesting in financial products involves risk. Losses may exceed the value of your original investment.  Pepperstone74.8% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
|